Aarti Drugs Limited Investor Relations Material
Latest events
Q4 24/25
Aarti Drugs Limited
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Aarti Drugs Limited
Access all reports
Aarti Drugs Limited is an India-based pharmaceutical company engaged in the manufacturing and marketing of active pharmaceutical ingredients (APIs), formulations, and specialty chemicals. The company produces APIs across various therapeutic categories, including antibiotics, anti-inflammatory, antidiabetic, and cardiovascular drugs. It also manufactures finished dosage forms for domestic and international markets. Aarti Drugs operates multiple manufacturing facilities and focuses on research and development to enhance its product portfolio. The company is headquartered in Mumbai, India, and its shares are listed on the NSE and BSE.
Key slides for Aarti Drugs Limited
Q4 24/25
Aarti Drugs Limited
Q4 24/25
Aarti Drugs Limited
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
524348
Country
🇮🇳 India